UBS Group
GDRX icon

UBS Group’s GoodRx Holdings GDRX Stock Holding History

UBS Group’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-125,000
Closed -$2.42M – 10534
2022
Q1 		$2.42M Buy
125,000
+100,000
+400% +$2.29M ﹤0.01% 3253
2021
Q4 		$817K Sell
25,000
-75,000
-75% -$3.02M ﹤0.01% 4563
2021
Q3 		$4.1M Buy
+100,000
New +$3.63M ﹤0.01% 2886

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

UBS Group's GDRX Position: Q1 2026 in Review

UBS Group increased its GoodRx Holdings (GDRX) stake by 24% in Q1 2026, buying an estimated $374K and bringing the position to 826,912 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #5162.

UBS Group first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $37.2M in Q1 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • UBS Group held 826,912 shares of GoodRx Holdings worth $1.62M as of Q1 2026.
  • UBS Group bought 159,465 GoodRx Holdings shares in Q1 2026, an estimated $374K.
  • GoodRx Holdings made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5162 holding.
  • UBS Group first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
  • UBS Group's GoodRx Holdings position peaked at $37.2M in Q1 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.